Chemours (NYSE: CC) reported Q4 EPS of $0.03, $0.05 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.36 billion.

For earnings history and earnings-related data on Chemours (CC) click here.